Sign in Join
Daily desk

News

Artificial intelligence, technology, science, health and education — reported daily, with the original source attached to every item.

3 stories

Split cards contrast PATHFINDER 2's 60.3% positive predictive value against NHS-Galleri's missed primary endpoint, framed as "two trials, one blood test, different verdicts."
🩺 Health Study

Two Nature Medicine Trials of a Multi-Cancer Blood Test Reach Different Verdicts on the Same Day

Published the same day in Nature Medicine, PATHFINDER 2 and the NHS-Galleri trial reach different verdicts on GRAIL's Galleri blood test: s…

EduFabTech · 1h ago · 5 min read
A prior estimate of 30-50% overdiagnosis is crossed out and replaced by the new JNCI reanalysis finding of under 5%.
🩺 Health Study

Reanalysis of Eight Mammography Trials Puts Breast Cancer Overdiagnosis Below 5%, Not 30-50%

A JNCI meta-analysis of eight randomized mammography trials, published 14 September 2026, finds overdiagnosis rates below 5% rather than th…

EduFabTech · 2d ago · 4 min read
A blood-drop icon holding ten microRNA markers plus CA19-9 illustrates the PANXEON score, alongside its 86.8% stage I-II sensitivity, 96.8% specificity, and 1,785-patient cohort.
🩺 Health Study

A Blood-Based Score Combining Ten microRNAs and CA19-9 Flags Early Pancreatic Cancer in a 1,785-Person Study

A prospective 1,785-person study published in Nature Medicine on September 16, 2026, found that PANXEON — a blood test combining ten microR…

EduFabTech · 17 Sep 2026 · 4 min read